Design and characterization of MP0250, a tri-specific anti-HGF/anti-VEGF DARPin® drug candidate.
Binz HK, Bakker TR, Phillips DJ, Cornelius A, Zitt C, Göttler T, Sigrist G, Fiedler U, Ekawardhani S, Dolado I, Saliba JA, Tresch G, Proba K, Stumpp MT.
Binz HK, et al. Among authors: proba k.
MAbs. 2017 Nov/Dec;9(8):1262-1269. doi: 10.1080/19420862.2017.1305529.
MAbs. 2017.
PMID: 29035637
Free PMC article.